A Three-Period Study to Investigate the Relative Bioavailability and Pharmacodynamic Profiles of a Zegerid 20mg Capsule, Zegerid 20mg Powder for Oral Suspension and Losec 20mg Capsule in Healthy Adult Volunteers Under Fasting Conditions

Acid Reflux Clinical Trial

Official title:
A Randomised, Three-Period, Single Dose, Open-Label, Crossover Study to Investigate the Relative Bioavailability and Pharmacodynamic Profiles of a Zegerid 20mg Capsule, Zegerid 20mg Powder for Oral Suspension and Losec 20mg Capsule in Healthy Adult Volunteers Under Fasting Conditions

Status Completed

Clinical Trial Summary

The purpose of this study is to assess the effectiveness of Zegerid 20mg capsules and powder and Losec 20mg capsules in healthy volunteers under fasting conditions.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Acid Reflux
Gastro Oesophageal Reflux Disease
Gastroesophageal Reflux

Clinical Trial Details

NCT number	NCT01710995
Study type	Interventional
Source	Norgine
Contact
Status	Completed
Phase	Phase 1
Start date	October 2010
Completion date	February 2011

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT06241183` - Famotidine and Antacids for Treatment of Dyspepsia	Phase 4
Terminated	`NCT02749071` - An Investigation of the EndoStim® Lower Esophageal Sphincter (LES) Stimulation System for the Treatment of Reflux	N/A
Recruiting	`NCT04883567` - The Use of AI to Improve Quality of OGD
Completed	`NCT03516188` - Efficacy of Gaviscon-Advance® in Suppressing Post-supper Acid-pocket and Night-time Acid-reflux in Obese Participants	Phase 2/Phase 3
Completed	`NCT01705275` - A Study to Investigate the Effect of ONO-8539 on Acid-Induced Oesophageal Hypersensitivity in Healthy Volunteers	Phase 1
Withdrawn	`NCT02700087` - In Infants With Laryngomalacia, Does Acid-Blocking Medication Improve Respiratory Symptoms?	N/A
Completed	`NCT02226484` - Can Quercetin Increase Claudin-4 and Improve Esophageal Barrier Function in GERD?	Phase 1